Harmony Biosciences Holdings (HRMY) Treasury Shares (2019 - 2026)
Harmony Biosciences Holdings (HRMY) posted Treasury Shares of $1.0 million for Q1 2026, up 31.69% sequentially from $796498.0 in Q4 2025, and up 11.08% YoY from $944252.0 in Q1 2025.
Harmony Biosciences Holdings (HRMY) Treasury Shares (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported Treasury Shares for 8 years, with the latest figure at $1.0 million in Q1 2026.
- Quarterly Treasury Shares rose 11.08% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 11.08% YoY) and the FY2025 annual result came in at $796498.0, up 24.67% from the prior year.
- Treasury Shares advanced to $1.0 million in Q1 2026 per HRMY's latest filing, from $796498.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $1.0 million in Q1 2026 and troughed at $43208.0 in Q1 2023.
- A 5-year average of $464702.4 and a median of $638900.0 in 2024 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2023 and 2024: Treasury Shares retreated 27.99% in 2023, then surged 1696.77% in 2024.
- Over 5 years, Treasury Shares stood at $60000.0 in 2022, then soared by 450.0% to $330000.0 in 2023, then surged by 93.61% to $638900.0 in 2024, then increased by 24.67% to $796498.0 in 2025, then jumped by 31.69% to $1.0 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $1.0 million, $796498.0, and $799587.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | 907,336.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 907,336.00 |
| Jun 30, 2026 | 907,336.00 |
| Mar 31, 2026 | 1.05 Mn |
| Mar 31, 2026 | 1.05 Mn |
| Dec 31, 2025 | 796,498.00 |
| Dec 31, 2025 | 796,498.00 |
| Sep 30, 2025 | 799,587.00 |
| Sep 30, 2025 | 799,587.00 |
| Jun 30, 2025 | 847,264.00 |
| Jun 30, 2025 | 847,264.00 |
| Mar 31, 2025 | 944,252.00 |
| Mar 31, 2025 | 944,252.00 |
| Dec 31, 2024 | 638,900.00 |
| Dec 31, 2024 | 638,900.00 |
| Sep 30, 2024 | 646,400.00 |
| Sep 30, 2024 | 646,400.00 |
| Jun 30, 2024 | 776,350.00 |
| Jun 30, 2024 | 776,350.00 |
| Mar 31, 2024 | 702,150.00 |
| Mar 31, 2024 | 702,150.00 |